Who backs Convergent Therapeutics?
4 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| OrbiMed | Growth equity |
| Novo Holdings | Other |
| The Invus Group | PE / buyout |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Convergent Therapeutics investors
4 investors are on record for Convergent Therapeutics, including RA Capital Management, OrbiMed, Novo Holdings and The Invus Group. The early-stage round in Jul 2024 drew 1 investor.
Free account
More of Convergent Therapeutics with a free account
- ·Watch Convergent Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 4 firms already write checks for companies like Convergent Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View